Get access to our best features
Get access to our best features
Published 9 months ago

A trial is underway that could be 'the last roll of the dice' for an HIV vaccine this decade

  • A novel trial called PrEPVacc is being conducted to test the efficacy of two HIV vaccines and two forms of pre-exposure prophylaxis in preventing the spread of HIV. The success of this trial could mark a new phase of vaccine development, while failure could lead to a setback for HIV vaccine research.
  • The medical community has been searching for an HIV vaccine for nearly 40 years, with only one clinical trial showing modest effectiveness in preventing infection. The PrEPVacc trial aims for an efficacy rate of at least 70% for the tested vaccines.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 93% of the sources are Center
93% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)